ALK

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

ALK
Nov 28, 2024, 12:35 | Blog
David R. Spigel: Putting the Pieces Together - Looking at Lung Cancer
David R. Spigel, Chief Scientific Officer at Sarah Cannon Research Institute, shared a post on…
Nov 21, 2024, 12:57 | Insight
Navneet Singh: Molecular testing in all stages of NSCLC
Navneet Singh, A Thoracic Medical Oncologist and a Professor at PGIMER, shared an article on…
Oct 8, 2024, 01:55 | Blog
Giannis Mountzios: Anne-Marie Dingemans on novel approaches for EGFR and ALK positive disease
Giannis Mountzios, Medical Oncologist, 2nd Oncology Department and Clinical Trials Unit, Henary Dunant Hospital Center,…
Sep 23, 2024, 09:48 | Insight
Heidi Ko: Alarming Biomarker Testing Gaps in NSCLC
Heidi Ko, Medical Director, Medical Affairs, Labcorp Drug Development, posted the following on LinkedIn: “These…
Aug 8, 2024, 02:34 | Blog
Dr. Isabel Preeshagul will discuss perioperative targeted therapy for lung cancer at DCLung24
Stephen V Liu shared on X: “Dr. Isabel Preeshagul will discuss perioperative targeted therapy for…
Jul 30, 2024, 01:45 | Insight
TKIs with vs without upfront SRS for EGFR+ and ALK+ NSCLC and brain metastasis
Biagio Ricciuti shared on X about a recent paper by Luke Pike et al. titled…
Jul 25, 2024, 21:48 | Insight
Stephen V Liu: What is the role for SRS to brain metastases up front for EGFR or ALK NSCLC?
Stephen V Liu shared a paper by Luke R.G. Pike et al. on X, adding: “What…
Jul 25, 2024, 14:02 | Insight
Erman Akkus: Should up-front SRS be added to TKI in brain metastatic EGFR/ALK positive NSCLC?
Erman Akkus, Medical Oncologist at Ankara University, shared a paper by Luke R.G. Pike et al. on…
Jul 11, 2024, 14:39 | Insight
Tejas Patil: DeepPT predicts tumor mRNA expression from hematoxylin and eosin slides
Tejas Patil, Thoracic oncologist at University of Colorado Cancer Center, shared a paper by Danh-Tai…
Jun 24, 2024, 15:19 | Insight
Vivek Subbiah: Precision therapy with ALK inhibitor in ALCL
Vivek Subbiah shared on X:          .  "Precision therapy with anaplastic lymphoma…
Jun 21, 2024, 04:15 | Insight
Biagio Ricciuti: Fusion partners and chromosomal breakpoints of oncogenic fusions are not stochastic
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Jun 10, 2024, 09:53 | Blog
We are proud to be members of Lung Cancer Europe - Oncogene Cancer Research
Oncogene Cancer Research recently shared a post by Lung Cancer Europe on LinkedIn, adding: "We…
May 19, 2024, 14:53 | Insight
Sergio Cifuentes Canaval: KN 189 and 407 - Pooled Analysis of Outcomes
Sergio Cifuentes Canaval, Student Fellow at National Autonomous University of Mexico, shared on LinkedIn: "KN 189…
All: 13 Posts: 1 - 100
Special Coverage